Argenica Therapeutics Limited (ASX:AGN)
Australia · Delayed Price · Currency is AUD 0.6800
-0.0200 (-2.86%)
Jul 29, 2025, 2:55 PM AEST
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 87.34 million as of July 28, 2025. Its market cap has decreased by -19.31% in one year.
Market Cap
87.34M
Enterprise Value
72.27M
Revenue
3.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.68
Market Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has increased from 19.02M to 87.34M, an increase of 359.10%. That is a compound annual growth rate of 44.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 89.91M | 11.42% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
| Jun 11, 2021 | 19.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 129.73B |
| Pro Medicus | 33.52B |
| Cochlear | 20.46B |
| Sonic Healthcare | 13.87B |
| Ramsay Health Care | 8.87B |
| Telix Pharmaceuticals | 7.19B |
| Ansell | 4.47B |
| Mesoblast | 3.19B |